Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: No  Market Cap: 3 M  90-day average vol: 61,188

Previous close: 0.0581  Open: 0.060875  Bid:   Ask:
52 week range    
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ARDS Income Statement

Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends1 M4 M
Amortization of intangibles-5000.0-6000.05000.05000.05000.0
Basic EPS from continuing operations-2.44-3.77-1.62
Basic EPS total-0.43-2.44-3.77-1.62
Basic weighted shares outstanding3 M8 M9 M12 M19 M
Cost of sales44 M33 M
Diluted EPS total-7.45-3.51-2.44-3.77-1.62
Diluted normalized net income/share-3.51-3.77
Diluted weighted shares outstanding3 M8 M12 M19 M
Earnings from equity interest-40000.0-951000.0-9000.0
GeneralAndAdministrativeExpense4 M6 M6 M7 M7 M
Gross operating profit1 M1000000.02 M3 M
Income before tax-22 M-30 M-22 M-46 M-30 M
Income taxes-1000.0-840000.0-92000.0759000.0435000.0
Interest income420000.0357000.077000.0-245000.0-121000.0
MinorityInterests-9 M
MiscOtherSpecialCharges4 M1 M3 M796000.093000.0
Net income from total operations-22 M-30 M-22 M-42 M-30 M
NetIncomeCommonStockholders-23 M-30 M-22 M-46 M-30 M
NetIncomeContinuousOperations-22 M-30 M-22 M-42 M-30 M
Operating income-27 M-29 M-22 M-43 M-30 M
Operating income before depreciation (EBITDA)-22 M-29 M-22 M-46 M-30 M
OperatingExpense27 M30 M23 M44 M33 M
Other income net-4 M951000.09000.03 M-93000.0
OtherGandA4 M6 M6 M7 M7 M
OtherWriteDown4 M
OtherunderPreferredStockDividend1 M4 M
PreferredStockDividends1 M4 M
RentAndLandingFees4 M
Research & development expense23 M24 M17 M37 M26 M
ResearchExpense23 M24 M17 M37 M26 M
Revenue per share-5000.0-6000.05000.05000.05000.0
SalariesAndWages-2 M-2 M2 M-2 M
Selling Gen & administrative expense4 M6 M6 M7 M7 M
Special income/charges-227000.0
Total Income available for interest expense (EBIT)-22 M-30 M-22 M-46 M-30 M
Total common shares outstanding8 M9 M11 M18 M36 M
Total net income-22 M-30 M-22 M-42 M-30 M
Total ordinary shares45 M45 M45 M45 M45 M
Total revenues3 M1 M1000000.02 M3 M
TotalExpenses27 M30 M23 M88 M-66 M
TotalRevenue3 M1 M1000000.02 M3 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University